Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Theranostics Market Segmentation
Frequently Asked Questions
2023 is the base year and 2030 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
1. Executive Summary
2. Global Theranostics Market Introduction
2.1. Global Theranostics Market - Taxonomy
2.2. Global Theranostics Market - Definitions
2.2.1. By Molecules
2.2.2. By Therapeutic Areas
2.2.3. By Region
3. Global Theranostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
3.8. USP
3.9. Macro Trends
4. Global Theranostics Market Analysis, 2018-2022 and Forecast 2023-2029
4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.3. Market Opportunity Analysis
5. Global Theranostics Market By Molecules, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Iodine-131
5.1.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Lutetium-177
5.2.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Iodine-123
5.3.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Yttrium-86/Yttrium-90
5.4.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Terbium Isotopes (Tb)
5.5.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Others
5.6.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
6. Global Theranostics Market By Therapeutic Areas, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Thyroid Cancer
6.1.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Bone Metastasis
6.2.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Neuroendocrine Neoplasia
6.3.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Prostate Carcinoma
6.4.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Metastatic Melanoma
6.5.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Others
6.6.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
6.Global Theranostics Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. North America
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Europe
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Asia Pacific (APAC)
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Middle East and Africa (MEA)
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Latin America
6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Global Theranostics Market - Opportunity Analysis Index, By Therapeutic Areas, Molecules, and Region, 2023-2029
7. North America Global Theranostics Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Molecules Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
7.1.1. Iodine-131
7.1.2. Lutetium-177
7.1.3. Iodine-123
7.1.4. Yttrium-86/Yttrium-90
7.1.5. Terbium Isotopes (Tb)
7.1.6. Others
7.2. Therapeutic Areas Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
7.2.1. Thyroid Cancer
7.2.2. Bone Metastasis
7.2.3. Neuroendocrine Neoplasia
7.2.4. Prostate Carcinoma
7.2.5. Metastatic Melanoma
7.2.6. Others
7.3. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
7.3.1. United States of America (USA)
7.3.2. Canada
8. Europe Global Theranostics Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. Molecules Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
8.1.1. Iodine-131
8.1.2. Lutetium-177
8.1.3. Iodine-123
8.1.4. Yttrium-86/Yttrium-90
8.1.5. Terbium Isotopes (Tb)
8.1.6. Others
8.2. Therapeutic Areas Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
8.2.1. Thyroid Cancer
8.2.2. Bone Metastasis
8.2.3. Neuroendocrine Neoplasia
8.2.4. Prostate Carcinoma
8.2.5. Metastatic Melanoma
8.2.6. Others
8.3. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
8.3.1. Germany
8.3.2. France
8.3.3. Italy
8.3.4. United Kingdom (UK)
8.3.5. Spain
8.3.6. Rest of EU
9. Asia Pacific (APAC) Global Theranostics Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Molecules Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.1.1. Iodine-131
9.1.2. Lutetium-177
9.1.3. Iodine-123
9.1.4. Yttrium-86/Yttrium-90
9.1.5. Terbium Isotopes (Tb)
9.1.6. Others
9.2. Therapeutic Areas Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.2.1. Thyroid Cancer
9.2.2. Bone Metastasis
9.2.3. Neuroendocrine Neoplasia
9.2.4. Prostate Carcinoma
9.2.5. Metastatic Melanoma
9.2.6. Others
9.3. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.3.1. China
9.3.2. India
9.3.3. Australia and New Zealand (ANZ)
9.3.4. Japan
9.3.5. Rest of APAC
10. Middle East and Africa (MEA) Global Theranostics Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Molecules Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.1.1. Iodine-131
10.1.2. Lutetium-177
10.1.3. Iodine-123
10.1.4. Yttrium-86/Yttrium-90
10.1.5. Terbium Isotopes (Tb)
10.1.6. Others
10.2. Therapeutic Areas Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.2.1. Thyroid Cancer
10.2.2. Bone Metastasis
10.2.3. Neuroendocrine Neoplasia
10.2.4. Prostate Carcinoma
10.2.5. Metastatic Melanoma
10.2.6. Others
10.3. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.3.1. GCC Countries
10.3.2. South Africa
10.3.3. Rest of MEA
11. Latin America Global Theranostics Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Molecules Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.1.1. Iodine-131
11.1.2. Lutetium-177
11.1.3. Iodine-123
11.1.4. Yttrium-86/Yttrium-90
11.1.5. Terbium Isotopes (Tb)
11.1.6. Others
11.2. Therapeutic Areas Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.2.1. Thyroid Cancer
11.2.2. Bone Metastasis
11.2.3. Neuroendocrine Neoplasia
11.2.4. Prostate Carcinoma
11.2.5. Metastatic Melanoma
11.2.6. Others
11.3. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of LA
12. Competition Landscape
12.1. Strategic Dashboard of Top Market Players
12.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis)
12.2.1. Thermo Fisher Scientific Inc.
12.2.2. Beckman Coulter, Inc.
12.2.3. Hoffmann La Roche Ltd.
12.2.4. Focus Diagnostics
12.2.5. Illumina Inc.
12.2.6. Agilent Technologies Inc.
12.2.7. QIAGEN
12.2.8. Abbott Laboratories
12.2.9. Myriad Genetics Inc.
12.2.10. Foundation Medicine Inc.
13. Research Methodology
14. Key Assumptions and Acronyms
2. Global Theranostics Market Introduction
2.1. Global Theranostics Market - Taxonomy
2.2. Global Theranostics Market - Definitions
2.2.1. By Molecules
2.2.2. By Therapeutic Areas
2.2.3. By Region
3. Global Theranostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
3.8. USP
3.9. Macro Trends
4. Global Theranostics Market Analysis, 2018-2022 and Forecast 2023-2029
4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.3. Market Opportunity Analysis
5. Global Theranostics Market By Molecules, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Iodine-131
5.1.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Lutetium-177
5.2.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Iodine-123
5.3.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Yttrium-86/Yttrium-90
5.4.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Terbium Isotopes (Tb)
5.5.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Others
5.6.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
6. Global Theranostics Market By Therapeutic Areas, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Thyroid Cancer
6.1.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Bone Metastasis
6.2.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Neuroendocrine Neoplasia
6.3.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Prostate Carcinoma
6.4.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Metastatic Melanoma
6.5.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Others
6.6.1. Market Analysis, 2018-2022 and Forecast,.2023-2029, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
6.Global Theranostics Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. North America
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Europe
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Asia Pacific (APAC)
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Middle East and Africa (MEA)
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Latin America
6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Global Theranostics Market - Opportunity Analysis Index, By Therapeutic Areas, Molecules, and Region, 2023-2029
7. North America Global Theranostics Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Molecules Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
7.1.1. Iodine-131
7.1.2. Lutetium-177
7.1.3. Iodine-123
7.1.4. Yttrium-86/Yttrium-90
7.1.5. Terbium Isotopes (Tb)
7.1.6. Others
7.2. Therapeutic Areas Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
7.2.1. Thyroid Cancer
7.2.2. Bone Metastasis
7.2.3. Neuroendocrine Neoplasia
7.2.4. Prostate Carcinoma
7.2.5. Metastatic Melanoma
7.2.6. Others
7.3. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
7.3.1. United States of America (USA)
7.3.2. Canada
8. Europe Global Theranostics Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. Molecules Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
8.1.1. Iodine-131
8.1.2. Lutetium-177
8.1.3. Iodine-123
8.1.4. Yttrium-86/Yttrium-90
8.1.5. Terbium Isotopes (Tb)
8.1.6. Others
8.2. Therapeutic Areas Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
8.2.1. Thyroid Cancer
8.2.2. Bone Metastasis
8.2.3. Neuroendocrine Neoplasia
8.2.4. Prostate Carcinoma
8.2.5. Metastatic Melanoma
8.2.6. Others
8.3. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
8.3.1. Germany
8.3.2. France
8.3.3. Italy
8.3.4. United Kingdom (UK)
8.3.5. Spain
8.3.6. Rest of EU
9. Asia Pacific (APAC) Global Theranostics Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Molecules Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.1.1. Iodine-131
9.1.2. Lutetium-177
9.1.3. Iodine-123
9.1.4. Yttrium-86/Yttrium-90
9.1.5. Terbium Isotopes (Tb)
9.1.6. Others
9.2. Therapeutic Areas Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.2.1. Thyroid Cancer
9.2.2. Bone Metastasis
9.2.3. Neuroendocrine Neoplasia
9.2.4. Prostate Carcinoma
9.2.5. Metastatic Melanoma
9.2.6. Others
9.3. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
9.3.1. China
9.3.2. India
9.3.3. Australia and New Zealand (ANZ)
9.3.4. Japan
9.3.5. Rest of APAC
10. Middle East and Africa (MEA) Global Theranostics Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Molecules Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.1.1. Iodine-131
10.1.2. Lutetium-177
10.1.3. Iodine-123
10.1.4. Yttrium-86/Yttrium-90
10.1.5. Terbium Isotopes (Tb)
10.1.6. Others
10.2. Therapeutic Areas Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.2.1. Thyroid Cancer
10.2.2. Bone Metastasis
10.2.3. Neuroendocrine Neoplasia
10.2.4. Prostate Carcinoma
10.2.5. Metastatic Melanoma
10.2.6. Others
10.3. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.3.1. GCC Countries
10.3.2. South Africa
10.3.3. Rest of MEA
11. Latin America Global Theranostics Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Molecules Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.1.1. Iodine-131
11.1.2. Lutetium-177
11.1.3. Iodine-123
11.1.4. Yttrium-86/Yttrium-90
11.1.5. Terbium Isotopes (Tb)
11.1.6. Others
11.2. Therapeutic Areas Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.2.1. Thyroid Cancer
11.2.2. Bone Metastasis
11.2.3. Neuroendocrine Neoplasia
11.2.4. Prostate Carcinoma
11.2.5. Metastatic Melanoma
11.2.6. Others
11.3. Country Analysis, 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of LA
12. Competition Landscape
12.1. Strategic Dashboard of Top Market Players
12.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis)
12.2.1. Thermo Fisher Scientific Inc.
12.2.2. Beckman Coulter, Inc.
12.2.3. Hoffmann La Roche Ltd.
12.2.4. Focus Diagnostics
12.2.5. Illumina Inc.
12.2.6. Agilent Technologies Inc.
12.2.7. QIAGEN
12.2.8. Abbott Laboratories
12.2.9. Myriad Genetics Inc.
12.2.10. Foundation Medicine Inc.
13. Research Methodology
14. Key Assumptions and Acronyms
Thermo Fisher Scientific Inc.
Beckman Coulter, Inc.
Hoffmann La Roche Ltd.
Focus Diagnostics
Illumina Inc.
Agilent Technologies Inc.
QIAGEN
Abbott Laboratories
Myriad Genetics Inc.
Foundation Medicine Inc.
Beckman Coulter, Inc.
Hoffmann La Roche Ltd.
Focus Diagnostics
Illumina Inc.
Agilent Technologies Inc.
QIAGEN
Abbott Laboratories
Myriad Genetics Inc.
Foundation Medicine Inc.